Literature DB >> 9220514

Complications of Fleet enema administration and suggested guidelines for use in the pediatric emergency department.

L Harrington1, S Schuh.   

Abstract

INTRODUCTION: Hypertonic sodium phosphate enema solutions are commonly used for the treatment of acute constipation in the pediatric emergency department. The potential for severe metabolic derangement and death in children with gastrointestinal and/or renal abnormalities and these reported as normal has been documented in the literature.
OBJECTIVE: To develop guidelines for the safe and effective use of hypertonic sodium phosphate enema solutions such as Fleet enema, in the pediatric emergency department setting. RESOURCES: A comprehensive review of the literature was conducted using the MEDLINE database for the time period 1966 to September 1995. Resources used within our institution, the Hospital for Sick Children, Toronto, Ontario, included Staff of the Emergency and General Surgery Departments.
SUMMARY: The guidelines provided will promote safe use of hypertonic sodium phosphate enema solutions for the treatment of acute constipation in children presenting to the emergency department.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220514     DOI: 10.1097/00006565-199706000-00014

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  4 in total

1.  All medications can be lethal.

Authors: 
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

Review 2.  Constipation in children.

Authors:  Merit M Tabbers; Nicole Boluyt; Marjolein Y Berger; Marc A Benninga
Journal:  BMJ Clin Evid       Date:  2010-04-06

3.  Respiratory failure requiring extracorporeal membrane oxygenation after sodium phosphate enema intoxication.

Authors:  David B Everman; Mara E Nitu; Brian R Jacobs
Journal:  Eur J Pediatr       Date:  2003-05-24       Impact factor: 3.183

Review 4.  Bowel management for the treatment of pediatric fecal incontinence.

Authors:  Andrea Bischoff; Marc A Levitt; Alberto Peña
Journal:  Pediatr Surg Int       Date:  2009-10-15       Impact factor: 1.827

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.